openPR Logo
Press release

Deadline on March 25th coming up for Investors in shares of Evolution AB (publ) (OTC: EVVTY)

03-26-2024 04:56 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on March 25, 2024 in the lawsuit for certain investors in Evolution AB (publ) (OTC: EVVTY).

A Deadline is coming up on March 25, 2024 in the lawsuit for certain investors in Evolution AB (publ) (OTC: EVVTY).

The Shareholders Foundation announced that a deadline is coming up on March 25, 2024 in the lawsuit filed for certain investors of Evolution AB (publ) (OTC: EVVTY).

Investors who purchased shares of Evolution AB (publ) (OTC: EVVTY) have certain options and there are strict and short deadlines running. Deadline: March 25, 2024. Evolution AB (publ) (OTC: EVVTY) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Eastern District of Pennsylvania the plaintiff alleges on behalf of purchasers of Evolution AB (publ) (OTC: EVVTY) common shares between February 14, 2019 and October 25, 2023, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 14, 2019 and October 25, 2023, the defendants made materially false and/or misleading statements regarding Evolution's and Evolution's customers' compliance with governing laws; the effect of non-compliance on Evolution's revenue; and Evolution's predicted growth and growth strategies. From January 24, 2022 to October 26, 2023, a number of disclosures revealed the truth of Evolution's compliance, revenue, and growth, and brought to light the falsities behind Defendants statements, and that as a result, Evolution AB saw a significant change in the value of its share prices, including its American Depository Shares ("ADSs").

Those who purchased shares of Evolution AB (publ) (OTC: EVVTY) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline on March 25th coming up for Investors in shares of Evolution AB (publ) (OTC: EVVTY) here

News-ID: 3441749 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors in FMC Corporation (NYSE: FMC) over potential Wrongdoing
Investigation announced for Investors in FMC Corporation (NYSE: FMC) over potent …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of FMC Corporation. Investors who are current long term investors in FMC Corporation (NYSE: FMC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: FMC stocks follows a lawsuit filed against FMC Corporation over
Investigation announced for Long-Term Investors who lost money with Advance Auto Parts, Inc. (NYSE: AAP)
Investigation announced for Long-Term Investors who lost money with Advance Auto …
An investigation was announced for long-term investors in shares of Advance Auto Parts, Inc. (NYSE: AAP) concerning potential breaches of fiduciary duties by certain directors of Advance Auto Parts, Inc. Investors who are current long term investors in Advance Auto Parts, Inc. (NYSE: AAP) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long
Investigation announced for Investors in Treace Medical Concepts, Inc. (NASDAQ: TMCI) over potential Wrongdoing
Investigation announced for Investors in Treace Medical Concepts, Inc. (NASDAQ: …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Treace Medical Concepts, Inc. Investors who purchased shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Treace Medical Concepts, Inc. directors breached their fiduciary duties and caused damage to the company and its
Deadline on May 20th coming up in Lawsuit for Investors in the Chemours Company (NYSE: CC)
Deadline on May 20th coming up in Lawsuit for Investors in the Chemours Company …
A deadline is coming up on May 20, 2024 in the lawsuit filed for certain investors of The Chemours Company (NYSE: CC) over alleged securities laws violations by The Chemours Company. Investors who purchased shares of The Chemours Company (NYSE: CC) have certain options and there are strict and short deadlines running. Deadline: May 20, 2024. NYSE: CC stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Evolution

Technology Evolution on Telemedicine Market
The rise in geriatric population and the increasing demand for proper healthcare and medical services to suffice to their needs is boosting the global telemedicine market says Fortune Business Insights in their new study. The study is titled "Telemedicine Market Size, Share and Global Trend By Type (Products, Services), By Application (Teleradiology, m Telepathology, Teledermatology, Telepsychiatry, Telecardiology, Others), By Modality (Store-and-forward (Asynchronous), Real-time (Synchronous), Others), By End User (Healthcare Facilities,
CiMi.CON Evolution Award 2018
Berlin, July 5, 2018 – At the CiMi.CON Evolution 2018, held from July 2-4, gathered the top experts in the industry. Co-Hosted with the Pharma CiMi.CON, these two conferences provide a unique glimpse into the fascinating world of competitive and market intelligence. Over 300 attendees participated in this year’s event, which offers a diverse range of topics and formats. On the evening of day one, the CI experts took part
Transdermal Scopolamine Market Evolution / Developments
A new study by Transparency Market Research (TMR) indicates that Novartis AG, alone, contributed nearly 41.0% of the overall revenue of the global transdermal scopolamine market in 2016. Other two torch bearers in the market, namely, GlaxoSmithKline Plc and Baxter International Inc., commanded a cumulative share of 49.0% in the same year. Even though, the number of small players in the market is less, the degree of competition within the
Evolution Of The Rhytidectomy
In the last recent years, there has been significant development in the facial surgery and not only there has been a growth in the quantity but in quality as well. This consistent growth has led to greater understanding of facial anatomy and the aging process. Subcutaneous Facelift Earlier the technique focused on the small local incisions which were near the hairline in the natural creases with excision of skin strips, but nowadays
Slimis Evolution in Health
World first Slimis: With counterbalance weight Evolution in the gym: Slimis have complained insoles that you wear comfortable in shoes and enjoying themselves. The result from Slimis training is amazing. disappear back leg and foot pain, the joy of sports is increasing. Even cellulite makes Slimis legs, and no gym or other training expenses. Sweating in the center or hours of jogging is not for everyone - and often lack a regular
Evolution - Trafo Meets Display
Reliable Reliability and safety - the most important attributes in generator and transformer technology. The Optocon AG developed for this purpose the fiber optic thermometer FOTEMPTrafo, that supports you effective in these areas. To ensure a constant and guaranteed operational safety, the temperatures are monitored at critical points in transformers and generators permanently. In combination FOTEMPTrafo with the fiber optic temperature probe TSTrafo and the innovative measurement method, allows accurate and precise